Market Insights & Analysis from Kramer Capital Research


When Everyone Else’s Sell Signal Means “Buy”

August 16, 2019

This was the week everybody discovered the yield curve and how closely it’s linked to recession risk. I don’t know where these people were hiding over the past year. The middle of the curve started getting tight last August. Segments started inverting on Dec. 3. We discussed it at the time. A few weeks later, […]

FedEx Makes It Official: Amazon Isn’t the Partner It Wants

August 9, 2019

We saw the writing on the wall months ago, but now FedEx Corp. (NYSE:FDX) has confirmed that, as of Sept. 1, its trucks will no longer carry packages from Inc. (NASDAQ:AMZN). Evidently, some partnerships just aren’t worth the headache. While FDX will take a slight hit, the strategic rewards of letting Jeff Bezos concoct […]

The Fed Gives Unto Apple What the Trade War Takes Away

August 2, 2019

In many corners of Wall Street, Apple Inc. (NASDAQ:AAPL) has become a good, but slightly dull, stock because of the sheer amount of cash and controversy it takes to get a $900 billion behemoth moving. That’s why this week’s seven-percent surge and slide feels so unreal. One day’s rally created $50 billion in wealth for […]

The Nasdaq Will Lag While FANG Growth Drags

July 26, 2019

Now that Inc. (NASDAQ:AMZN) and Alphabet Inc. (NASDAQ:GOOG) have reported their 2Q19 results, Big Tech looks closer than ever to hitting a collective wall. I don’t hate these companies or their smaller counterparts in the “FANG” group: Facebook Inc. (NASDAQ:FB) and Netflix Inc. (NASDAQ:NFLX). They provide essential services to hundreds of millions of people. […]

No Question: No Recession

July 12, 2019

It has been 10 years since the last economic contraction and a lot of investors feel like we’re living on borrowed time. As far as I can see, the only things they have to be afraid of are their own shadows. This isn’t just my native optimism talking or even the privilege of having a […]

Go Below the Radar for Post-FAANG Wall Street Leadership

July 5, 2019

The market is buzzing about records again for the first time since September. So, after the best first half since the dot-com boom and the best June since the Eisenhower era, why aren’t investors cheering? Look to the calendar for answers, since the best rally in decades only feels good if you bought the bottom […]

No Trade Deal? No Big Deal

June 28, 2019

If you’re wondering where all the Federal Reserve euphoria went, look toward Osaka, Japan, where investors around the world will be looking this weekend for hints of either a trade breakthrough or a full-fledged global breakdown. As far as I’m concerned, the G20 summit is always more noise than substance. Big deals don’t get made […]

Iran Creates a New Wall of Worry but Oil Investors Profit

June 21, 2019

The last fraction of fear around a “trade war” evaporated yesterday, with the S&P 500 pushing to new records despite the ongoing chatter about a freeze of sales to Chinese companies. Naturally, today’s headlines raise the question of the implications of a literal war, this one with Iran. There always is a fresh fear factor […]

Cannabis 3.0: The Party All Investors Can Enjoy

May 31, 2019

Big Cannabis stocks like Tilray Inc. (NASDAQ:TLRY) and Aurora Cannabis Inc. (NYSE:ACB) never really recovered from last year’s broad market correction. Whether they will ever recover their loftiest levels isn’t really my concern. Those companies were born in a vision of a long-prohibited industry finally running free after generations of being legislated out of existence. […]

Don’t Sell in May When the Catalysts Stack to the Upside

May 10, 2019

When the market futures dropped Sunday night in line with the market opening in Shanghai, I knew it was the kind of dip investors could buy and ultimately be rewarded for doing. After all, a trade deal is coming sooner or later. President Trump and the Chinese both need one to make their respective constituencies […]

Exclusive Report: 3 Biotech Breakthroughs To Bank On
Hilary Kramer
Legendary Wall St. trader Hilary Kramer

Where does the Smart Money look for the best biotech stocks? Small- and mid-cap biotechs. They're the ones with the ability to transform the world, and bring investors transformational profits. To get free access to Hilary Kramer's latest report, 3 Biotech Breakthroughs To Bank On, simply tell us where to send it in the box below.

Along with my FREE report, Hilary Kramer's 3 Biotech Breakthroughs to Bank On, please also send Hilary's free weekly e-letter, Trading Desk.
* We value your privacy. You will not be spammed, ever. Period.

Log In

Forgot Password